The distinction is clinically relevant, as BED occurs in individuals of normal weight, and the risk-benefit profile of Saxenda may differ in this population
Early Diagnosis : Emphasize the importance of seeking medical evaluation promptly upon experiencing symptoms suggestive of Graves disease
IP administration creates rapid systemic spikes and clearance, triggering acute stress-response pathways
However, an analysis of 966 subjects who received statins in Phase 3 trials of exenatide (51% atorvastatin, 31% simvastatin, 11% pravastatin, 5% lovastatin, 3% fluvastatin) showed comparable lipid-lowering statin effects compared to placebo [20]
Each person responds differently to medications, and the degree of weight loss achieved with treatment can vary based on personal factors, said Priya Jaisinghani, MD, a clinical assistant professor specializing in obesity medicine at the NYU Grossman School of Medicine